Table 5.
Bangladesh | Nepal | Pakistan | ||||
---|---|---|---|---|---|---|
Univariable (n = 4868) | Multivariablea (n = 3003) | Univariable (n = 1595) | Multivariablea (n = 519) | Univariable (n = 2206 | Multivariablea (n = 1548) | |
Age in years | ||||||
<2 | 2.82 (2.21, 3.60)* | 5.51 (1.90, 16.01)* | 1.74 (.67, 4.53) | 3.19 (.41, 24.96) | .83 (.62, 1.11) | .70 (.48, 1.03) |
2–4 | 2.17 (1.80, 2.64)* | 3.87 (1.35, 11.10)* | .76 (.37, 1.55) | 2.31 (.75, 7.15) | .92 (.72, 1.17) | .73 (.53, 1.02) |
5–15 | 1.61 (1.34, 1.93)* | 3.10 (1.08, 8.90)* | 1.47 (1.14, 1.89)* | 3.10 (2.01, 4.80)* | 1.00 (.80, 1.26) | .99 (.73, 1.33) |
≥16 | Ref | Ref | Ref | Ref | Ref | Ref |
Gender | ||||||
Female | Ref | Ref | Ref | Ref | Ref | Ref |
Male | 1.00 (.88, 1.14) | .91 (.78, 1.07) | .70 (.55, .86)* | .78 (.51, 1.28) | 1.09 (.92, 1.29) | 1.16 (.93, 1.45) |
Species | ||||||
S. Paratyphi A | Ref | Ref | Ref | Ref | Ref | Ref |
S. Typhi | 1.67 (1.37, 2.03)* | 1.43 (1.10, 1.84)* | 1.51 (1.09, 2.11)* | 1.58 (.91, 2.74) | 2.41 (1.63, 3.56)* | 1.70 (1.05, 2.74)* |
Fluoroquinolone sensitivity | ||||||
Susceptible | Ref | Ref | Ref | Ref | Ref | Ref |
Reduced susceptibility | 1.57 (.93, 2.63) | 2.64 (1.27, 5.48)* | .88 (.64, 1.22) | .84 (.45, 1.59) | 2.84 (1.81, 4.47)* | 1.98 (1.18, 3.32)* |
Third-generation cephalosporin sensitivityb | ||||||
Susceptible | Ref | Ref | Ref | Ref | Ref | Ref |
Resistant | … | … | … | … | 2.07 (1.74, 2.47)* | 1.78 (1.40, 2.27)* |
Prior antibiotic use | ||||||
No | Ref | Ref | Ref | Ref | Ref | Ref |
Yes | 1.75 (1.53, 1.99)* | 1.32 (1.12, 1.56)* | 1.62 (1.27, 2.07)* | 1.33 (.61, 2.00) | 1.78 (1.50, 2.11)* | 2.05 (1.62, 2.58)* |
Days from fever onset to hospital presentationc | ||||||
<3 days | Ref | Ref | Ref | Ref | Ref | Ref |
3–5 days | 1.14 (.87, 1.49) | 1.11 (.85, 1.46) | 1.17 (.67, 2.06) | 1.10 (.61, 2.00) | .68 (.42, 1.07) | .61 (.38, .99)* |
6–9 days | 2.04 (1.55, 2.69)* | 1.87 (1.40, 2.47)* | 2.86 (1.56, 5.25)* | 2.53 (1.32, 4.85)* | 1.53 (.97, 2.43) | 1.17 (.72, 1.90) |
≥10 days | 2.70 (1.89, 3.87)* | 2.55 (1.76, 3.69)* | 2.46 (1.21, 5.01)* | 2.31 (1.08, 4.92)* | 3.67 (2.27, 5.93)* | 2.47 (1.50, 4.14)* |
Data are presented as ORs (95% CI). *P < .05.
Abbreviations: CI, confidence interval; OR, odds ratio; Ref, reference.
aMultivariable models include patients recruited from SEAP hospitals only.
bCephalosporin resistance only detected in Pakistan.
cFor SEAP hospital patients only; data not available for laboratory network patients.